Patient Time Requirements for Anticoagulation Therapy with Warfarin

被引:25
作者
Jonas, Daniel E. [1 ]
Shilliday, Betsy Bryant [1 ,2 ]
Laundon, W. Russell [2 ]
Pignone, Michael [1 ]
机构
[1] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Sch Pharm, Chapel Hill, NC 27599 USA
关键词
anticoagulation; warfarin; time; human capital method; health economics; COST-EFFECTIVENESS; ORAL ANTICOAGULATION; BREAST-CANCER; MANAGEMENT; CARE; RECOMMENDATIONS; QUALITY; HEALTH; TRAVEL; WOMEN;
D O I
10.1177/0272989X09343960
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background. Most patients receiving warfarin are managed in outpatient office settings or anticoagulation clinics that require frequent visits for monitoring. Objective. To measure the amount and value of time required of patients for chronic anticoagulation therapy with warfarin. Design/Participants. Prospective observation of a cohort of adult patients treated at a university-based anticoagulation program. Measurements. Participants completed a questionnaire and a prospective diary of the time required for 1 visit to the anticoagulation clinic, including travel, waiting, and the clinic visit. The authors reviewed subjects' medical records to obtain additional information, including the frequency of visits to the anticoagulation clinic. They used the human capital method to estimate the value of time. Results. Eighty-five subjects completed the study. The mean (median) total time per visit was 147 minutes (123). Subjects averaged 15 visits per year (14) and spent 39.0 hours (29.3) per year on their visits. Other anticoagulation-related activities, such as communication with providers, pharmacy trips, and extra time preparing food, added an average of 52.7 hours (19.0) per year. The mean annual value of patient time spent traveling, waiting, and attending anticoagulation visits was $707 (median $591). The mean annual value when also including other anticoagulation-related activities was $1799 (median $1132). Conclusions. The time required of patients for anticoagulation visits was considerable, averaging approximately 2.5 hours per visit and almost 40 hours per year. Methods for reducing patient time requirements, such as home-based testing, could reduce costs for patients, employers, and companions.
引用
收藏
页码:206 / 216
页数:11
相关论文
共 49 条
  • [1] *AHRQ, AHRQ ANN GUID HELP P
  • [2] [Anonymous], 2010, HEALTH ECON
  • [3] [Anonymous], 1996, COST EFFECTIVENESS H, DOI DOI 10.1093/OSO/9780195108248.001.0001
  • [4] [Anonymous], [No title captured]
  • [5] Pharmacology and management of the vitamin K antagonists
    Ansell, Jack
    Hirsh, Jack
    Hylek, Elaine
    Jacobson, Alan
    Crowther, Mark
    Palareti, Gualtiero
    [J]. CHEST, 2008, 133 (06) : 160S - 198S
  • [6] COST-EFFECTIVENESS OF MONITORING WARFARIN THERAPY USING STANDARD VERSUS CAPILLARY PROTHROMBIN TIMES
    ANSELL, JE
    HAMKE, AK
    HOLDEN, A
    KNAPIC, N
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1989, 91 (05) : 587 - 589
  • [7] Attard NJ, 2005, INT J PROSTHODONT, V18, P117
  • [8] Cost implications of routine mammography screening of women 50-69 years in the County of Funen, Denmark
    Bech, M
    Gyrd-Hansen, D
    [J]. HEALTH POLICY, 2000, 54 (02) : 125 - 141
  • [9] *BRIST MYERS SQUIB, 2008, ROL VIT K COUMADIN U
  • [10] Bryan S, 1995, J Med Screen, V2, P62